Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel.
Kim A PappBarbara MeloskySandeep SehdevSebastien J HotteJennifer R BeeckerMark G KirchhofIrina TurchinJan P DutzMelinda J GooderhamRobert GniadeckiChih-Ho HongJo LambertCharles W LyndeVimal H PrajapatiRonald B VenderPublished in: Dermatology and therapy (2023)
Prior to considering new therapies for psoriasis, an understanding of cancer prognosis should be addressed. Patients with TSTs and a good cancer prognosis will have similar outcomes to non-TST patients when treated with systemic psoriasis therapies. For patients with TSTs and a poor cancer prognosis, the quality-of-life benefits of treating psoriasis may outweigh the theoretical risks.